Related references
Note: Only part of the references are listed.Secretoneurin as a Novel Biomarker of Cardiovascular Episodes: Are We There Yet? A Narrative Review
Jiri Plasek et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Biological variation of secretoneurin; a novel cardiovascular biomarker implicated in arrhythmogenesis
Kristin M. Aakre et al.
CLINICAL BIOCHEMISTRY (2021)
Performance of a Novel Research-Use-Only Secretoneurin ELISA in Patients with Suspected Acute Coronary Syndrome: Comparison with an Established Secretoneurin Radioimmunoassay
Peder L. Myhre et al.
CARDIOLOGY (2021)
Catecholaminergic Polymorphic Ventricular Tachycardia
Chan W. Kim et al.
CARDIOLOGY IN REVIEW (2020)
Circulating Secretoneurin Concentrations After Cardiac Surgery: Data From the FINNish Acute Kidney Injury Heart Study
Jon Brynildsen et al.
CRITICAL CARE MEDICINE (2019)
Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca2+-Dependent Arrhythmia
Anett H. Ottesen et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2019)
Circulating secretoneurin concentrations in patients with moderate to severe aortic stenosis
Jon Brynildsen et al.
CLINICAL BIOCHEMISTRY (2019)
Novel biomarkers of cardiovascular disease: Applications in clinical practice
Magnus Nakrem Lyngbakken et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2019)
Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study
Helge Rosjo et al.
CRITICAL CARE MEDICINE (2018)
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction A Randomized Clinical Trial
G. Michael Felker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Prognostic Value of Secretoneurin in Patients with Acute Respiratory Failure: Data from the FINNALI Study
Peder L. Myhre et al.
CLINICAL CHEMISTRY (2016)
Prognostic Value of Secretoneurin in Critically III Patients With Infections
Helge Rosjo et al.
CRITICAL CARE MEDICINE (2016)
Secretoneurin Is a Novel Prognostic Cardiovascular Biomarker Associated With Cardiomyocyte Calcium Handling
Anett Hellebo Ottesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Effect of short- and long-term physical activities on circulating granin protein levels
Helge Rosjo et al.
REGULATORY PEPTIDES (2013)
Secretogranin II; a Protein Increased in the Myocardium and Circulation in Heart Failure with Cardioprotective Properties
Helge Rosjo et al.
PLOS ONE (2012)
Heart Failure 1 In search of new therapeutic targets and strategies for heart failure: recent advances in basic science
Ajay M. Shah et al.
LANCET (2011)
Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial
Helge Rosjo et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure
L Tavazzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Mechanisms of disease - The chromogranin-secretogranin family.
L Taupenot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure - The Valsartan Heart Failure Trial (Val-HeFT)
R Latini et al.
CIRCULATION (2002)
Share Paper
